"A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy." Neurology
92.18
(2019):
e2109-e2117.
Web. 28 Nov. 2023.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
